Načítá se...
A potentially deleterious new CYP2C9 polymorphism identified in an African American patient with major hemorrhage on warfarin therapy
Possession of a variant Cytochrome P450 2C9 (CYP2C9) genotype has been associated with a higher risk of hemorrhagic complications among warfarin users. [1; 2] Although the influence of the common variant alleles (CYP2C9*2, CYP2C9*3) on warfarin response is well documented that of other rare defectiv...
Uloženo v:
| Hlavní autoři: | , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2008
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2662477/ https://ncbi.nlm.nih.gov/pubmed/19083245 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcmd.2008.10.011 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|